FindMyKOL

Valeria Duarte, MD

Basic profile

Cardiovascular Disease

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionHouston, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Valeria Duarte is a Cardiology physician. OpenAlex indexes 64 publications with 821 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
64publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

821citations

Citations across these publications.

12h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Medtronic, Inc.
    Program year20255 payments
    $412
  • Abbott Laboratories
    Program year20253 payments
    $245
  • Biosense Webster, Inc.
    Program year20251 payment
    $135
All 26 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.6%
    Statin20.6%
    Rosuvastatin Calcium65%Atorvastatin Calcium35%
    Part D<11 patients
    Beta blocker15.9%
    Metoprolol Succinate67%Carvedilol33%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    14.4%
    SGLT2 inhibitor7.8%
    Jardiance56%Farxiga44%
    Part D<11 patients
    Potassium supplement6.6%
    Potassium Chloride100%
    Part D<11 patients
  • Blood & clotting

    10%
    Factor Xa inhibitor5.9%
    Eliquis100%
    Part D<11 patients
    Vitamin K antagonist4.1%
    Warfarin Sodium100%
    Part D<11 patients
Where care is delivered (Part B)80.1% facility · 19.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”